C22orf26 Antikörper (AA 51-138) (AbBy Fluor® 680)
-
- Target Alle C22orf26 (C22ORF26) Produkte
- C22orf26 (C22ORF26) (Chromosome 22 Open Reading Frame 26 (C22ORF26))
- Bindungsspezifität
- AA 51-138
- Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser C22orf26 Antikörper ist konjugiert mit AbBy Fluor® 680
-
Applikation
- Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
- Homologie
- Human
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human C22orf26
- Isotyp
- IgG
-
-
- Applikationshinweise
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- Haltbarkeit
- 12 months
-
- Target
- C22orf26 (C22ORF26) (Chromosome 22 Open Reading Frame 26 (C22ORF26))
- Andere Bezeichnung
- C22orf26 (C22ORF26 Produkte)
- Synonyme
- proline rich 34 antikoerper, PRR34 antikoerper
- Hintergrund
-
Synonyms: C22orf26, Chromosome 22 open reading frame 26, CV026_HUMAN, FLJ10945, Putative uncharacterized protein C22orf26.
Background: Chromosome 22 contains over 500 genes and about 49 million bases. Being the second smallest human chromosome, 22 contains a surprising variety of interesting genes. Phelan-McDermid syndrome, neurofibromatosis type 2 and autism are associated with chromosome 22. A schizophrenia susceptibility locus has been identified on chromosome 22 and studies show that 22q11 deletion symptoms include a high incidence of schizophrenia. Translo-acations between chromosomes 9 and 22 may lead to the formation of the Philadelphia chromosome and the subsequent production of the novel fusion protein, Bcr-Abl, a potent cell proliferation activator found in several types of leukemia. The C22orf26 gene product has been provisionally designated C22orf26 pending further characterization.
- Gen-ID
- 55267
-